PEAK6
VRTX icon

PEAK6’s Vertex Pharmaceuticals VRTX Stock Holding History

PEAK6’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$37.7M Sell
72,200
-12,000
-14% -$6.14M 0.07% 193
2026
Q2 		$41.8M Buy
84,200
+74,300
+751% +$32.9M 0.09% 196
2026
Q1 		$4.42M Sell
9,900
-18,100
-65% -$8.44M 0.01% 963
2025
Q4 		$12.7M Buy
28,000
+17,500
+167% +$7.54M 0.02% 537
2025
Q3 		$4.11M Buy
10,500
+6,900
+192% +$2.88M 0.01% 1125
2025
Q2 		$1.6M Sell
3,600
-10,100
-74% -$4.65M ﹤0.01% 1559
2025
Q1 		$6.64M Buy
13,700
+1,300
+10% +$606K 0.01% 764
2024
Q4 		$4.99M Buy
+12,400
New +$5.75M 0.01% 908

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

PEAK6's VRTX Position: Q3 2026 in Review

PEAK6 opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 2 shares worth $800. The stake represents ﹤0.01% of the portfolio and ranks #2513 among its holdings. This is a return to the name: PEAK6 previously reported a position in VRTX as recently as Q1 2026.

PEAK6 first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.6M in Q2 2025. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • PEAK6 held 2 shares of Vertex Pharmaceuticals worth $800 as of Q3 2026.
  • Vertex Pharmaceuticals was a new PEAK6 position in Q3 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of PEAK6's portfolio in Q3 2026, its #2513 holding.
  • PEAK6 first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • PEAK6's Vertex Pharmaceuticals position peaked at $13.6M in Q2 2025.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.